Antipsychotics in pregnancy up postnatal risks

Researchers from Monash University followed 147 pregnant women listed on the National Register of Antipsychotic Medications in Pregnancy, established in 2005 to monitor pregnant women taking medication for varying psychiatric disorders and establish safe dosage levels for anti-psychotic drugs.

The women had an average age of 32 years, were classified as having moderate to severe psychiatric disease and 22% developed gestational diabetes.

Medications included atypical antipsychotics such as quetiapine, olanzapine, and risperidone while 11 women used a typical antipsychotic such as haloperidol. Doses were

Latest

Trending